Suppr超能文献

微小病变病的细胞生物学与遗传学

Cell biology and genetics of minimal change disease.

作者信息

Saleem Moin A, Kobayashi Yasuko

机构信息

Paediatric Renal Medicine, University of Bristol, Bristol, UK; Children's Renal Unit, Bristol Royal Hospital for Children, Bristol, UK.

Paediatric Renal Medicine, University of Bristol, Bristol, UK; Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

出版信息

F1000Res. 2016 Mar 30;5. doi: 10.12688/f1000research.7300.1. eCollection 2016.

Abstract

Minimal change disease (MCD) is an important cause of nephrotic syndrome and is characterized by massive proteinuria and hypoalbuminemia, resulting in edema and hypercholesterolemia. The podocyte plays a key role in filtration and its disruption results in a dramatic loss of function leading to proteinuria. Immunologic disturbance has been suggested in the pathogenesis of MCD. Because of its clinical features, such as recurrent relapse/remission course, steroid response in most patients, and rare familial cases, a genetic defect has been thought to be less likely in MCD. Recent progress in whole-exome sequencing reveals pathogenic mutations in familial cases in steroid-sensitive nephrotic syndrome (SSNS) and sheds light on possible mechanisms and key molecules in podocytes in MCD. On the other hand, in the majority of cases, the existence of circulating permeability factors has been implicated along with T lymphocyte dysfunction. Observations of benefit with rituximab added B cell involvement to the disease. Animal models are unsatisfactory, and the humanized mouse may be a good model that well reflects MCD pathophysiology to investigate suggested "T cell dysfunction" directly related to podocytes in vivo. Several candidate circulating factors and their effects on podocytes have been proposed but are still not sufficient to explain whole mechanisms and clinical features in MCD. Another circulating factor disease is focal segmental glomerulosclerosis (FSGS), and it is not clear if this is a distinct entity, or on the same spectrum, implicating the same circulating factor(s). These patients are mostly steroid resistant and often have a rapid relapse after transplantation. In clinical practice, predicting relapse or disease activity and response to steroids is important and is an area where novel biomarkers can be developed based on our growing knowledge of podocyte signaling pathways. In this review, we discuss recent findings in genetics and podocyte biology in MCD.

摘要

微小病变病(MCD)是肾病综合征的重要病因,其特征为大量蛋白尿和低白蛋白血症,导致水肿和高胆固醇血症。足细胞在滤过过程中起关键作用,其破坏会导致功能急剧丧失,进而引发蛋白尿。免疫紊乱被认为与MCD的发病机制有关。由于其临床特征,如复发/缓解病程、大多数患者对类固醇有反应以及罕见的家族病例,人们认为MCD发生遗传缺陷的可能性较小。全外显子测序的最新进展揭示了类固醇敏感性肾病综合征(SSNS)家族病例中的致病突变,并阐明了MCD中足细胞的可能机制和关键分子。另一方面,在大多数病例中,循环通透性因子的存在与T淋巴细胞功能障碍有关。利妥昔单抗治疗有效的观察结果提示B细胞也参与了该疾病。动物模型并不理想,人源化小鼠可能是一个很好的模型,能够很好地反映MCD的病理生理学,从而直接在体内研究与足细胞直接相关的“T细胞功能障碍”。已经提出了几种候选循环因子及其对足细胞的影响,但仍不足以解释MCD的整个机制和临床特征。另一种循环因子相关疾病是局灶节段性肾小球硬化(FSGS),目前尚不清楚它是否是一个独立的实体,还是与MCD在同一谱系上,涉及相同的循环因子。这些患者大多对类固醇耐药,移植后常迅速复发。在临床实践中,预测复发或疾病活动以及对类固醇的反应很重要,并且基于我们对足细胞信号通路不断增长的认识,这是一个可以开发新型生物标志物的领域。在这篇综述中,我们讨论了MCD在遗传学和足细胞生物学方面的最新发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec4/4821284/4c94b7b425cc/f1000research-5-7868-g0000.jpg

相似文献

1
Cell biology and genetics of minimal change disease.
F1000Res. 2016 Mar 30;5. doi: 10.12688/f1000research.7300.1. eCollection 2016.
2
Molecular Mechanisms of Proteinuria in Minimal Change Disease.
Front Med (Lausanne). 2021 Dec 23;8:761600. doi: 10.3389/fmed.2021.761600. eCollection 2021.
3
Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.
Front Med (Lausanne). 2018 Jun 11;5:170. doi: 10.3389/fmed.2018.00170. eCollection 2018.
4
Nephrotic syndrome: immunological mechanisms.
J Biol Regul Homeost Agents. 2019 Sep-Oct;33(5 Suppl. 1):13-18. Special Issue: Focus on Pediatric Nephrology.
7
Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
J Am Soc Nephrol. 1997 May;8(5):824-32. doi: 10.1681/ASN.V85824.
8
Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Clin Exp Nephrol. 2013 Dec;17(6):811-8. doi: 10.1007/s10157-013-0775-y. Epub 2013 Feb 2.
9
10
The efficacy and safety of rituximab in adult patients with steroid-dependent or frequent relapsing nephrotic syndrome: A retrospective study.
Int Immunopharmacol. 2025 Jun 17;158:114795. doi: 10.1016/j.intimp.2025.114795. Epub 2025 May 10.

引用本文的文献

1
Minimal Change Disease in a Young Adult With Neurofibromatosis Type 1.
Cureus. 2025 Jun 6;17(6):e85466. doi: 10.7759/cureus.85466. eCollection 2025 Jun.
2
RESOLVE: Recurrence Posttransplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Glomerular Dis. 2024 Dec 2;5(1):60-67. doi: 10.1159/000542839. eCollection 2025 Jan-Dec.
4
Anti-Tumor Necrosis Factor Treatment for Glomerulopathy: Case Report and Review of Literature.
Fed Pract. 2024 Aug;41(8):250-255. doi: 10.12788/fp.0506. Epub 2024 Aug 15.
6
Acute pulmonary embolism with arrhythmia associated with minimal change disease in adults: a case report.
Front Cardiovasc Med. 2023 Aug 8;10:1182569. doi: 10.3389/fcvm.2023.1182569. eCollection 2023.
7
Steroid Minimization in Adults with Minimal Change Disease.
Glomerular Dis. 2021 Jul 29;1(4):237-249. doi: 10.1159/000517626. eCollection 2021 Oct.
9
Minimal Change Disease in an Adult: A Case Report.
JNMA J Nepal Med Assoc. 2022 Apr 15;60(248):399-401. doi: 10.31729/jnma.7433.
10
Biopsy or Biomarker? Children With Minimal Change Disease Have a Distinct Profile of Urinary Epidermal Growth Factor.
Front Pediatr. 2021 Nov 25;9:727954. doi: 10.3389/fped.2021.727954. eCollection 2021.

本文引用的文献

1
Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F335-41. doi: 10.1152/ajprenal.00510.2015. Epub 2015 Dec 23.
4
KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
J Clin Invest. 2015 Jun;125(6):2375-84. doi: 10.1172/JCI79504. Epub 2015 May 11.
5
Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4080-5. doi: 10.1073/pnas.1418316112. Epub 2015 Mar 16.
6
One hundred ways to kill a podocyte.
Nephrol Dial Transplant. 2015 Aug;30(8):1266-71. doi: 10.1093/ndt/gfu363. Epub 2015 Jan 29.
7
Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):592-600. doi: 10.2215/CJN.06260614. Epub 2015 Jan 29.
8
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
Nephron Clin Pract. 2014;128(3-4):277-82. doi: 10.1159/000368590. Epub 2014 Nov 8.
9
HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.
J Am Soc Nephrol. 2015 Jul;26(7):1701-10. doi: 10.1681/ASN.2014030247. Epub 2014 Oct 27.
10
A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.
J Am Soc Nephrol. 2015 Jun;26(6):1279-89. doi: 10.1681/ASN.2014050489. Epub 2014 Oct 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验